Role of Liagamentum Teres Cardiopexy During Laparoscopic Sleeve Gastrectomy in Obese Patients With Gastro-esophageal Reflux Disease – A Short-Term Retrospective Study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202411894699760

Enrollment

Registered

2024-11-18

Start date

2020-10-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive System

Interventions

Laparoscopic sleeve gastrectomy with Hiatoplasty

Laparoscopic sleeve gastrectomy with Hiatoplasty and Ligamentum Teres Cardiopexy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Morbid obesity patients (with BMI>40 or with BMI>35 with co-morbidities) who were complaining of GERD symptoms that was confirmed by upper endoscopy and manometry or PH-metry were offered the LSG with hiatoplasty. Patients who completed the follow up (FU) requirements (FU period of at least 12 months followed by upper endoscopy and manometry) were included.

Exclusion criteria

Exclusion criteria: Patients who developed procedure-specific complications (as leakage or sleeve stricture) that required surgical re-intervention within the FU period, patients who did not complete the FU requirements (FU period of at least 12 months followed by upper endoscopy and manometry), patients with history of previous bariatric procedures, and patients diagnosed pre-operatively with large hiatus hernia ( > 5cm) were excluded from the study.

Design outcomes

Primary

Measure	Time frame
postoperative reflux or dysphagia symptoms, upper endoscopy and manometry findings	—

Secondary

Measure	Time frame
weight loss, procedure-specific complications	—

Countries

Egypt

Contacts

Public ContactFady Makram

Ain Shams University

Fedomak@med.asu.edu.eg00201225047204

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026